Campaign details
Brand: HardhatBrand owner: HardhatEntrant company: Hardhat - AustraliaIdea creation: In houseMarket: Australia & New ZealandSector: Business & industrialMedia channels: Word of mouth, Influencers, KOLs, Television & Connected TV, Online display, Outdoor, Out-of-home, Radio & audioBudget: No budget
Executive summary
In September 2021, Hardhat produced a pro-bono campaign to counter AstraZeneca vaccine hesitancy in Australia. The Australian government had purchased 53.8 million doses of AstraZeneca vaccine, or AZ had become colloquially known in Australia as their first choice vaccine. Then research emerged that there...